MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,930K
Free Cash flow
-$2,930K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Amortization of debt discount
Stock-based compensation expense
Inventory
Others
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other asset...
Purchases of property and equipm...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net loss
-4,050
6,248
-3,339
-6,385
Stock-based compensation expense
412
-1,016
58
1,289
Depreciation and amortization
60
-79
77
90
Amortization of debt discount
852
176
-
-
Change in fair value of derivative liabilities
-133
45
-
-
Amortization of operating right-of-use asset
68
-134
68
131
Provision for credit losses on accounts receivable
-5
11
0
0
Accounts receivable
-27
-166
541
-93
Inventory
-280
-802
484
70
Prepaid expenses and other assets
272
-225
-171
374
Accounts payable
-18
-465
-259
525
Accrued expenses
72
-563
499
142
Operating lease liability
-51
145
-74
-138
Net cash used in operating activities
-2,758
5,561
-3,824
-4,697
Purchase of assets from sivantage, inc
-
-
-750
-
Purchases of property and equipment
172
-25
-111
192
Cash used in investing activities
-172
775
-639
-192
Gross proceeds from issuance of common stock, prefunded warrants and warrants
-
-
-
4,010
Gross proceeds from issuance of series a convertible preferred stock
-
-
0
0
Gross proceeds from issuance of series b convertible preferred stock
-
-
0
-
Gross proceeds from issuance of common stock, prefunded warrants and warrants
-
-
4,010
-
Gross proceeds from issuance of common stock
-
-
0
0
Gross proceeds from issuance of common stock, prefunded warrants and warrants under inducement agreement
-
-
0
3,057
Gross proceeds from issuance of convertible notes
0
4,300
-
-
Gross proceeds from issuance of common stock upon exercise of warrants
-
-
0
-
Offering costs
0
-375
-59
867
Net cash provided by financing activities
0
-2,392
59
6,200
Effect of foreign currency translation on cash flow
-
-
0
0
Net (decrease) increase in cash and cash equivalents
-2,930
3,944
-4,404
1,311
Cash and cash equivalents at beginning of period
3,442
3,442
6,535
-
Cash and cash equivalents at end of period
1,677
4,607
3,442
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net (decrease)
increase in cash and cash...
-$2,930K
(-323.49%↓ Y/Y)
Amortization of debt discount
$852K
Stock-based compensation
expense
$412K
(-68.04%↓ Y/Y)
Inventory
-$280K
(-500.00%↓ Y/Y)
Accrued expenses
$72K
(-49.30%↓ Y/Y)
Amortization of operating
right-of-use asset
$68K
(-48.09%↓ Y/Y)
Depreciation and
amortization
$60K
(-33.33%↓ Y/Y)
Accounts receivable
-$27K
(70.97%↑ Y/Y)
Net cash used in
operating activities
-$2,758K
(41.28%↑ Y/Y)
Cash used in
investing activities
-$172K
(10.42%↑ Y/Y)
Canceled cashflow
$1,771K
Net loss
-$4,050K
(36.57%↑ Y/Y)
Purchases of property and
equipment
$172K
(-10.42%↓ Y/Y)
Prepaid expenses and
other assets
$272K
(-27.27%↓ Y/Y)
Change in fair value of
derivative liabilities
-$133K
Operating lease liability
-$51K
(63.04%↑ Y/Y)
Accounts payable
-$18K
(-103.43%↓ Y/Y)
Provision for credit
losses on accounts...
-$5K
Buy us a coffee
Tenon Medical, Inc. (TNONW)
Tenon Medical, Inc. (TNONW)